Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

Stefanski, H. E., Eaton, A., Baggott, C., Rossoff, J., Verneris, M. R., Prabhu, S., Pacenta, H. L., Phillips, C. L., Talano, J.-A., Moskop, A., Margossian, S. P., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, M. C., Keating, A. K., … Schultz, L. M. (2023). Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium. Blood Advances, 7(4), 541–548. https://doi.org/10.1182/bloodadvances.2022007246
Authors:
Heather E. Stefanski
Anne Eaton
Christina Baggott
Jenna Rossoff
Michael R. Verneris
Snehit Prabhu
Holly Pacenta
Christine L. Phillips
Julie-An Talano
Amy Moskop
Steven Margossian
Gary Douglas Myers
Nicole Karras
Patrick A. Brown
Muna Qayed
Michelle L. Hermiston
Prakash Satwani
M. Christa Krupski
Amy K. Keating
Rachel Wilcox
Cara A. Rabik
Vanessa A. Fabrizio
Vasant Chinnabhandar
A. Yasemin Goksenin
Kevin J. Curran
Crystal L. Mackall
Theodore W. Laetsch
Liora M. Schultz
Affiliated Authors:
Prakash Satwani
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2022007246
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: